Thinking of joining a study?

Register your interest

Become a volunteer?

NCT02902874 | COMPLETED | ALCL

Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
Sponsor:

Gustave Roussy, Campus Cancer, Grand Paris

Brief Summary:

To study the correlation between the polymorphism of the main immunity genes and progression-free survival in ALCL of the child.

Condition or disease

ALCL

Intervention/treatment

Blood sample

Phase

NA

Study Type : INTERVENTIONAL
Estimated Enrollment : 185 participants
Masking : NONE
Primary Purpose : BASIC_SCIENCE
Official Title : Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +
Actual Study Start Date : 2010-04-21
Estimated Primary Completion Date : 2020-12-31
Estimated Study Completion Date : 2020-12-31

Information not available for Arms and Intervention/treatment

Ages Eligible for Study:
Sexes Eligible for Study: ALL
Accepts Healthy Volunteers:
Criteria
Inclusion Criteria
  • * Every patients treated according to COPAD-IGR, HM 89,91 and 97 and ALCL99 protocols and included in related studies
  • * Clinical data registered in SFCE database
  • * Signed consent form
Exclusion Criteria
  • * No ALK expression on tumour
  • * No consent signed
Study of the Biological Mechanisms Associated With the Immunogenicity in Anaplastic Large Cell Lymphoma ( ALCL ) ALK +

Location Details

NCT02902874

Please Choose a site

How to Participate

Want to participate in this study, select a site at your convenience, send yourself email to get contact details and prescreening steps.

Locations

Not yet recruiting

France, De Marne Val

Gustave Roussy

Villejuif, The Valley of Marne, France, 94805